Story
Shein Shares Tumble After Quarterly Profit Plummets 67%

Summary
Shares of the fast-fashion retailer fell as much as 4.4% in Hong Kong trading after a steep decline in quarterly earnings fueled investor concerns about margin pressure and slowing growth.
Shares of fast-fashion retailer Shein dropped sharply on Tuesday after the company reported a significant decline in its quarterly profit, intensifying investor concerns over its growth trajectory and profitability.
Market Reaction
The company's stock fell by as much as 4.4% during Tuesday's trading session in Hong Kong, according to a report from Reuters. The shares were trading around HK$33.82 following the news.
The sell-off extends a difficult period for the company since its public listing. By Monday's market close, Shein's shares had already fallen 27.3% from their initial offer price.
Profit Decline Fuels Concerns
AdThe immediate trigger for the stock's decline was the company's announcement of a 67% fall in its quarterly profit. This steep earnings slide has heightened investor concerns regarding potential margin pressure and a slowdown in the company's previously rapid expansion.
Post-IPO Struggles
Shein's performance has been under close scrutiny since its stock market debut in Hong Kong on September 1. The company went public with an offer price of HK$48.56 ($6.19). The latest earnings report adds to the challenges facing the newly-listed retailer as it navigates a competitive global market.
Read next
More on Stocks
Nidec Stock Tumbles Amid CEO Resignation, Planned ¥1 Trillion Impairment
Shares of Japanese motor giant Nidec Corp. extended a steep two-day selloff following reports of its CEO's planned resignation and a massive ¥1 trillion writedown linked to its struggling electric vehicle business.

Navigator Global Shares Surge on $75M Invictus Stake Sale to New York Life
The alternative asset manager's stock jumped over 8% after it announced a deal to sell a 60% stake in Invictus Capital Partners, expecting up to $75 million in total proceeds.

China Stocks Edge Higher on Policy Support Pledge; Hong Kong Slips
Mainland Chinese stocks posted modest gains after Beijing pledged further economic support, particularly for the property sector, while Hong Kong shares declined amid thin pre-holiday trading.

Hengrui Pharma Shares Rise on $2.6 Billion Obesity Drug Deal with Novo Nordisk
Jiangsu Hengrui Pharmaceuticals saw its shares climb after securing a licensing agreement with Novo Nordisk for an experimental oral obesity and diabetes drug, with the deal valued at up to $2.6 billion.